Skip to main content

Table 1 Sociodemographic and clinical features of symptomatic SARS-CoV-2 positive children and adolescentsa diagnosed between 3/12/2020 and 9/28/2020b (n = 1000 unless otherwise specified)

From: The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study

Characteristic or clinical variable No. (%)
Age (y), median, IQR 14.0 (7.2–17.3)
Range 0.04–22.8
Age groups
 <1 year 87 (9)
 1–4 years 99 (10)
 5–9 years 140 (14)
 10–14 years 230 (23)
 ≥15 years 444 (44)
Gender, female 523 (52.3)
Racec
 White 789 (78.9)
 Black 129 (12.9)
 Asian 45 (4.5)
 Multiracial 72 (7.2)
 Other or Unknown 19 (1.9)
Hispanic ethnicity 203 (20.3)
Testing location
 Outpatient clinic or testing site 801 (80.1)
 Emergency department 197 (19.7)
 Hospital admission 2 (0.2)
Method of data collection
 Patient interview 237 (23.7 %)
 Medical record review 839 (83.9 %)
SARS-CoV-2 exposure
 Known household contact with COVID-19 409 (40.9)
 Known community contact with COVID-19 241 (24.1)
Days to return test results (mean ± SD) 1.1 ± 1.3
 Median (range) 1.0 (0–17)
Any comorbidity 177 (17.7)
Chronic lung disease 77 (7.7)
Neurologic condition 33 (3.3)
Cardiovascular disease 27 (2.7)
Diabetes mellitus 10 (1.0)
Immunocompromising condition 9 (0.9)
Chronic renal disease 8 (0.8)
Other chronic condition 65 (6.5)
Body mass index, median (IQR), n = 572 20.3 (17.1–23.8)
Underweight (BMI < 18.5) 165 (28.8)
Normal weight (BMI 18.5–24.9) 280 (49.0)
Overweight (BMI 25-29.9) 75 (13.1)
Obese (BMI ≥ 30) 52 (9.1)
Symptom resolution at early follow-up (n = 892) 398 (44.6)
Symptom resolution at later follow-up (n = 471) 443 (94.0)
Outcomes
 Hospitalization
  Remained outpatient 959 (95.9)
  Admitted to hospital 41 (4.1)
 ICU admission 8 (0.8)
 Mechanical ventilation 2 (0.2)
 Prescribed remdesivir 9 (0.9)
Death4 1 (0.1)
 Clinical symptoms
  Headache 424 (42.4)
  Sore throat 361 (36.1)
  Fever > 100.4 F (38.0 C) 337 (33.7)
  Nausea or vomiting 147 (14.7)
  Shortness of breath (dyspnea) 98 (9.8)
  Abdominal pain 82 (8.2)
  Vomiting 16 (1.6)
  Hypoxia 12 (1.2)
  1. aCohort includes 995 individuals < = 18 years of age and 5 individuals 19 and older who received long-term primary and subspecialty care in the pediatric facility (age range 19–22)
  2. bIncludes 1 infant who developed symptoms and positive SARS-CoV-2 test at 5 weeks of age after being born to mother who was SARS-CoV-2 positive at time of delivery
  3. cTotal n > 1000 as several subjects reported association with more than one race category
  4. dCause of death not definitively associated with SARS-CoV-2 infection in patient with multiple comorbidities